Omega-3 derivatives, specialized pro-resolving mediators: Promising therapeutic tools for the treatment of pain in chronic liver disease
- 1 July 2020
- journal article
- review article
- Published by Elsevier in Prostaglandins, Leukotrienes and Essential Fatty Acids
- Vol. 158, 102095
Abstract
No abstract availableKeywords
This publication has 139 references indexed in Scilit:
- Emerging roles of resolvins in the resolution of inflammation and painTrends in Neurosciences, 2011
- Resolvins and Protectins in Inflammation ResolutionChemical Reviews, 2011
- Spinal injection of TNF‐α‐activated astrocytes produces persistent pain symptom mechanical allodynia by releasing monocyte chemoattractant protein‐1Glia, 2010
- Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actionsNature Medicine, 2010
- Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsisNature, 2009
- Cellular and Molecular Mechanisms of PainCell, 2009
- Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural PlasticityThe Journal of Pain, 2009
- Quality of life in adults with nonalcoholic fatty liver diseaseHepatology, 2009
- Current and Future Anti-Fibrotic Therapies for Chronic Liver DiseaseClinics in Liver Disease, 2008
- From inflammation to sickness and depression: when the immune system subjugates the brainNature Reviews Neuroscience, 2008